US self-pay prices

ORRO Health GLP-1 prices

Last updated

Compounding

ORRO Health: prices at a glance

  • Compounded, not FDA-approved

    Compounded tirzepatide injection

    $299/4 weeks

  • Compounded, not FDA-approved

    Compounded semaglutide injection

    $335/4 weeks

Telehealth platform (ORRO Health Inc.) for weight loss, hormone and longevity care: independent licensed clinicians prescribe and 503A compounding pharmacies fill compounded semaglutide or tirzepatide, as a one-time 4-week supply or a 12-week plan that renews, with the consultation included (compounded is not FDA-approved). ORRO Health has 2 sourced self-pay GLP-1 offers here. Advertised entry prices: Compounded tirzepatide injection $299/4 weeks; Compounded semaglutide injection $335/4 weeks. Plan terms, fees and the check date are listed with each quote.

2 current prices · US self-pay · 0 maintenance quotes

  • Compounded semaglutide injection via ORRO Health

    Semaglutide · Compounded

    Compounded · Not FDA-approved
    Advertised price$335/4 weeks

    28-day supply (orrohealth.com)

    ≈ $358.93 per 30 days

    Checked on orrohealth.com

    Other plan lengths

    • $155/28 days on 3 months ($465 up front)
    Maintenance price

    No separate dose price verified

    View offer
    Price conditions & source

    Advertised price: the 1 Month (4 Weeks) Program, "One-time payment · No automatic renewal", $335 for 4 weeks; the 3 Months (12 Weeks) Program renews every 12 weeks at $465 ($155 per 4 weeks); clinician consultation, medication, needles and shipping included

    ORRO says "No hidden fees", that the "plan covers your consultation", and "Cancel anytime"; the 12-week plan auto-renews every 12 weeks. The page names no price by dose. Prescribed after clinician approval and "Compounded by our licensed 503A pharmacy partner." Compounded products are not FDA-approved.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.

    Read the advertised-price source (orrohealth.com)
  • Compounded tirzepatide injection via ORRO Health

    Tirzepatide · Compounded

    Compounded · Not FDA-approved
    Advertised price$299/4 weeks

    28-day supply (orrohealth.com)

    ≈ $320.36 per 30 days

    Checked on orrohealth.com

    Other plan lengths

    • $169/28 days on 3 months ($507 up front)
    Maintenance price

    No separate dose price verified

    View offer
    Price conditions & source

    Advertised price: the 1 Month (4 Weeks) Program, "One-time payment · No automatic renewal", $299 for 4 weeks; the 3 Months (12 Weeks) Program renews every 12 weeks at $507 ($169 per 4 weeks); clinician consultation, medication, needles and shipping included

    ORRO says "No hidden fees", that the "plan covers your consultation", and "Cancel anytime"; the 12-week plan auto-renews every 12 weeks. The page names no price by dose. Prescribed after clinician approval and "Compounded by our licensed 503A pharmacy partner." Compounded products are not FDA-approved.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.

    Read the advertised-price source (orrohealth.com)

Read prices in context. Compare the same product, dose, and payment terms. A prepaid monthly rate is not a monthly payment. Cost order uses current, recently checked quotes with documented supply periods, converted to 30 days. Other prices are unranked references. Dose changes, introductory terms and added fees affect what you pay.

Missing prices are not estimated. A listed maintenance dose is not a dosing recommendation.

FDA declared the tirzepatide (December 2024) and semaglutide (February 2025) shortages resolved. Its conditions for a pharmacy compounding them now include "The drug product is compounded for an individual patient based on receipt of a prescription" and "The compounder does not compound, regularly or in inordinate amounts, any that are essentially copies of a commercially available drug product." In May 2026 FDA proposed leaving semaglutide, tirzepatide and liraglutide off the 503B Bulks List, the ingredients outsourcing facilities may compound from; comments closed Jul 30, 2026, and we found no final notice when we last read the Federal Register (Nov 6, 2026). FDA's newest warning letter to a pharmacy over compounded semaglutide or tirzepatide went to Empower Clinic Services, LLC dba Empower Pharmacy on Sep 18, 2026 (every GLP-1 warning letter). FDA's newest recall report of a compounded semaglutide or tirzepatide product is Houston Rx LLC's tirzepatide, reported Oct 21, 2026: "Lack of assurance of sterility." (every tirzepatide recall). Liraglutide is different: FDA's shortage database still lists it in shortage (updated at source Oct 14, 2026; every GLP-1 shortage). FDA: "Compounded drugs are not FDA-approved. This means that FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed." A low price is not a low-risk signal; confirm current terms with the provider.

Questions

ORRO Health GLP-1 cost: common questions

How much does tirzepatide cost through ORRO Health?

Compounded tirzepatide injection: $299/4 weeks (the 1 Month (4 Weeks) Program, "One-time payment · No automatic renewal", $299 for 4 weeks; the 3 Months (12 Weeks) Program renews every 12 weeks at $507 ($169 per 4 weeks); clinician consultation, medication, needles and shipping included). Checked Nov 7, 2026; each quote names its source in the table. Compounded tirzepatide is not an FDA-approved product.

How much does semaglutide cost through ORRO Health?

Compounded semaglutide injection: $335/4 weeks (the 1 Month (4 Weeks) Program, "One-time payment · No automatic renewal", $335 for 4 weeks; the 3 Months (12 Weeks) Program renews every 12 weeks at $465 ($155 per 4 weeks); clinician consultation, medication, needles and shipping included). Checked Nov 7, 2026; each quote names its source in the table. Compounded semaglutide is not an FDA-approved product.

Is ORRO Health cheaper than other sellers?

ORRO Health charges about $359 per 30 days for compounded semaglutide ($335/4 weeks). For compounded semaglutide, 20 sellers whose price states its supply charge less; the lowest is Sunlight at about $84 per 30 days ($78/mo). ORRO Health charges about $320 per 30 days for compounded tirzepatide ($299/4 weeks). For compounded tirzepatide, 15 sellers whose price states its supply charge less; the lowest is Sunlight at about $149 per 30 days ($139/mo). Each seller counts once, at its lowest current price, and a compounded price is only set against other compounded prices. A lower price says nothing about a product's quality. Sellers that charge less than ORRO Health

Does ORRO Health offer FDA-approved GLP-1 medication or compounded versions?

The ORRO Health offers tracked here are compounded: Compounded tirzepatide injection; Compounded semaglutide injection. Compounded GLP-1s are not FDA-approved products and are not reviewed by the FDA for safety, effectiveness, or quality.

Does ORRO Health charge a membership fee?

No membership fee is charged beside the price: ORRO Health's own pages say the price includes the clinician's care with the medication, for Compounded tirzepatide injection; Compounded semaglutide injection.

When were ORRO Health prices last checked?

Each quote carries its own check date and names the page it was read from: Nov 7, 2026 for the offers here. A quote not rechecked within 21 days is kept as a dated reference and is no longer stated as a current price.

Does ORRO Health have a promo code?

We found no promo code or sale on ORRO Health's homepage when we read it on Nov 6, 2026. A sale can appear after that, and some sellers apply one only at checkout. We do not list codes from coupon sites, because we cannot confirm them. Every GLP-1 sale and promo code we can verify

Are you ORRO Health? See how sellers are listed, how to correct a price, and the badge listed sellers can show.

GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.